O
OrbiMed Portfolio holdings
AUM
$3.98B
1-Year Return
13.05%
This Quarter Return
+37.59%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.86B
AUM Growth
+$1.15B
(+17%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
39.67%
Holding
137
New
17
Increased
32
Reduced
42
Closed
9
Top Buys
| 1 |
AGN
ALLERGAN INC
AGN
|
$186M |
| 2 |
Intuitive Surgical
ISRG
|
$115M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$60.8M |
| 4 |
AbbVie
ABBV
|
$53.1M |
| 5 |
Neurocrine Biosciences
NBIX
|
$45.4M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$83.2M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$60M |
| 3 |
ITMN
INTERMUNE INC
ITMN
|
$58.4M |
| 4 |
UnitedHealth
UNH
|
$56.5M |
| 5 |
CELG
Celgene Corp
CELG
|
$53.8M |
Sector Composition
| 1 | Healthcare | 86.06% |
| 2 | Technology | 0.09% |
| 3 | Financials | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
26
DELISTED
Allergan plc
AGN
| $102M | 1.25% |
495,000
-218,000
| -31% | -$44.9M |
|
27
BioMarin Pharmaceuticals
BMRN
$10.9B
| $102M | 1.25% |
1,493,000
+78,900
| +6% | +$5.38M |
|
28
Insulet
PODD
$24.4B
| $91.7M | 1.13% |
1,933,500
-955,000
| -33% | -$45.3M |
|
|
29
Neurocrine Biosciences
NBIX
$13.9B
| $87.8M | 1.08% |
5,451,000
+2,820,000
| +107% | +$45.4M |
|
|
SHPG
30
DELISTED
Shire pic
SHPG
| $87.2M | 1.07% |
587,000
-137,000
| -19% | -$20.3M |
|
|
HNT
31
DELISTED
HEALTH NET INC
HNT
| $87.1M | 1.07% |
2,560,000
+998,600
| +64% | +$34M |
|
32
Molina Healthcare
MOH
$9.26B
| $84.6M | 1.04% |
2,253,000
+189,900
| +9% | +$7.13M |
|
|
CFN
33
DELISTED
CAREFUSION CORPORATION
CFN
| $80.9M | 1% |
2,012,000
-159,500
| -7% | -$6.42M |
|
|
STJ
34
DELISTED
St Jude Medical
STJ
| $75M | 0.92% |
1,146,600
+313,000
| +38% | +$20.5M |
|
35
Prothena Corp
PRTA
$442M
| $72.4M | 0.89% |
1,889,000
+687,000
| +57% | +$26.3M |
|
36
Zimmer Biomet
ZBH
$20.8B
| $67.7M | 0.83% |
737,686
-122,570
| -14% | -$11.3M |
|
|
XLRN
37
DELISTED
Acceleron Pharma Inc.
XLRN
| $64.4M | 0.79% |
1,867,800
-249,848
| -12% | -$8.62M |
|
38
Arrowhead Research
ARWR
$3.87B
| $64.2M | 0.79% |
3,910,000
+1,781,100
| +84% | +$29.2M |
|
39
Standard BioTools
LAB
$493M
| $63.8M | 0.78% |
1,447,200
+1,192
| +0.1% | +$52.5K |
|
40
Johnson & Johnson
JNJ
$431B
| $58.6M | 0.72% |
597,000
-29,000
| -5% | -$2.85M |
|
|
INFI
41
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $56.3M | 0.69% |
4,736,900
-57,400
| -1% | -$682K |
|
42
Stryker
SYK
$151B
| $51.1M | 0.63% |
626,700
-90,000
| -13% | -$7.33M |
|
|
AFFX
43
DELISTED
AFFYMETRIX INC
AFFX
| $47.7M | 0.59% |
6,693,000
-117,000
| -2% | -$834K |
|
44
OraSure Technologies
OSUR
$230M
| $42.8M | 0.53% |
5,372,000
+384,000
| +8% | +$3.06M |
|
45
Celldex Therapeutics
CLDX
$1.51B
| $41.5M | 0.51% |
156,507
+69,134
| +79% | +$18.3M |
|
|
ALXN
46
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $40.6M | 0.5% |
267,000
+34,100
| +15% | +$5.19M |
|
47
Eli Lilly
LLY
$666B
| $32M | 0.39% |
+543,000
| New | +$32M |
|
|
TRNX
48
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $31.3M | 0.38% |
+1,475,100
| New | +$31.3M |
|
|
ARRY
49
DELISTED
Array Biopharma Inc
ARRY
| $29.6M | 0.36% |
6,297,000
+972,000
| +18% | +$4.57M |
|
|
XNPT
50
DELISTED
XENOPORT, INC.
XNPT
| $28.7M | 0.35% |
5,546,100
+955,300
| +21% | +$4.94M |
|